Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LABT

Lakewood-Amedex Biotherapeutics Inc

Apr 27 • 12:44PM ET

4.23

-3.12 -42.45 %

Healthcare • Biotechnology • USA • Nano • NASD

Today, 9:31 AMPost-Nasdaq direct listing profit-taking and dilution concerns drive LABT's 21% drop.

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.69	Insider Own	-	Shs Outstand	7.00M	Perf Week	-
Market Cap	29.61M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	31.03M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-3.85M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-495.77%	Short Interest	-	Perf YTD	-51.10%
Book/sh	-0.28	P/C	123.38	EPS next 5Y	-	ROE	-	52W High	9.82 -56.92%	Perf Year	-
Cash/sh	0.03	P/FCF	-	EPS past 3/5Y	17.02% -	ROIC	-	52W Low	5.74 -26.37%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	3.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.13	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.13	EPS Q/Q	-225.00%	SMA20	-37.27%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-37.27%	Rel Volume	0.25	Prev Close	7.35
Employees	5	LT Debt/Eq	-	Earnings	-	SMA200	-37.27%	Avg Volume	2.67M	Price	4.23
IPO	Apr 23, 2026	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	346,329	Change	-42.45%

Apr-23-26 10:42AM

Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol "LABT"

(PR Newswire)

Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LABT

Lakewood-Amedex Biotherapeutics Inc

Upgrade your Finviz experience